1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS
4.1 Market Overview
4.2 Industry Attractiveness - Porter's Five Forces Analysis
4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers/Consumers
4.2.3 Threat of New Entrants
4.2.4 Threat of Substitute Products
4.2.5 Intensity of Competitive Rivalry
4.3 Industry Value Chain Analysis

5 MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increasing Geriatric Population
5.1.2 Increasing Geriatric Population
5.1.3 Increasing Investments in R&D
5.2 Market Restraints
5.2.1 Operational Challenges

6 MARKET SEGMENTATION
6.1 By Technology
6.1.1 Syringe/Extrusion Bioprinting
6.1.2 Inkjet Bioprinting
6.1.3 Magnetic Levitation Bioprinting
6.1.4 Laser-assisted Bioprinting
6.1.5 Other Technologies
6.2 By Component
6.2.1 3D Bioprinters
6.2.2 Biomaterials
6.2.3 Scaffolds
6.3 By Application
6.3.1 Drug Testing and Development
6.3.2 Regenerative Medicine
6.3.3 Food Testing
6.3.4 Research
6.3.5 Other Applications
6.4 Geography
6.4.1 North America
6.4.1.1 United States
6.4.1.2 Canada
6.4.2 Europe
6.4.2.1 Germany
6.4.2.2 United Kingdom
6.4.2.3 France
6.4.2.4 Rest of Europe
6.4.3 Asia-Pacific
6.4.3.1 China
6.4.3.2 Japan
6.4.3.3 India
6.4.3.4 South Korea
6.4.3.5 Rest of Asia-Pacific
6.4.4 Rest of the World

7 COMPETITIVE LANDSCAPE
7.1 Company Profiles
7.1.1 3D Systems Corporation
7.1.2 Aspect Biosystems Ltd
7.1.3 GeSIM GmbH
7.1.4 Allevi Inc.
7.1.5 Cyfuse Biomedical KK
7.1.6 Envision TEC GmbH
7.1.7 Organovo Holdings Inc.
7.1.8 RegenHU SA
7.1.9 Stratasys Ltd
7.1.10 REGEMAT 3D
7.1.11 3D Bioprinting Solutions
7.1.12 Arcam AB (GE Company)

8 INVESTMENT ANALYSIS

9 FUTURE OF THE MARKET

Companies Mentioned
 - 3D Systems Corporation
- Aspect Biosystems Ltd
- GeSIM GmbH
- Allevi Inc.
- Cyfuse Biomedical KK
- Envision TEC GmbH
- Organovo Holdings Inc.
- RegenHU SA
- Stratasys Ltd
- REGEMAT 3D
- 3D Bioprinting Solutions
- Arcam AB (GE Company)